We have collated a list of recommendations from top brokerage firms from ETNow and other sources:Macquarie on Paytm: Neutral| Target Rs 650BofA Securities on Sun Pharma: Neutral| Target Rs 1440Elara Capital on KEC International: Accumulate| Target Rs 700Elara Capital on M&M Financial Services: Accumulate| Target Rs 322Brokerage firm Macquarie maintained a neutral rating on Paytm, BofA Securities recommended a neutral rating on Sun Pharma , and Elara Capital maintained an accumulate rating on KEC International and M&M Financial Services.Macquarie maintained a neutral rating on Paytm with a target price of Rs 650. This effectively means that RBI is indirectly revoking the PPI (pre-paid instrument) license of Paytm.BofA Securities maintained a neutral rating on Sun Pharma but raised the target price to Rs 1440 from Rs 1370.The US & India growth is positive. The pharma major reported inline quarterly results. Earning drivers factored in its valuations.Elara Capital maintained an accumulate rating on KEC International with a target price of Rs 700.“We cut FY24E/25E/26E earnings 23%/13%/9% on lower EBITDA margin with higher interest cost. The efforts promise 25% EPS CAGR with RoA/RoE settling at 2%/5% by FY26E,” added the note.

Source: Economic Times February 01, 2024 10:50 UTC